#

Cathie Wood

: 59
Robotaxis could operate profitably even at lower fares, reckons Ark / Photo: Dolores M. Harvey / Shutterstock.com
News·
Why Cathie Wood’s team expects Tesla stock to rise more than 1,000%
Photo: Casimiro PT / Shutterstock
News·
CoreWeave's stock continued to fall. Huang and Wood were unable to sustain its rise
Iambic develops cancer drugs using its AI platform / Photo: Iambic
Small Caps·
Iambic IPO: Biotech backed by Nvidia and Cathie Wood debuts on the Nasdaq
The memory-chip sector is prone to “vicious” boom-and-bust cycles and the problem looks set to worsen as Chinese firms ramp up capacity, Wood says / Photo: LinkedIn / Catherinedwood
News·
Cathie Wood says ARK avoids memory-chip stocks due to ‘vicious’ cycles
Cathie Wood, through her investment firm ARK Invest, is one of the largest and most influential investors in biotechs using AI / Photo: Facebook / ARK Invest
Small Caps·
AI can halve drug development time. Here are 3 smaller AI biotechs Cathie Wood likes.
The technological revolution is already gaining momentum, but not everyone will be able to profit from it, according to Wood / Photo: ark-invest.com
News·
"A Golden Age for the Stock Market": Highlights from Cathie Wood's Letter to Investors
Several major investors cut their investments in memory chip manufacturers in the second quarter / Photo: CeltStudio / Shutterstock.com
News·
The Next Bet on AI: Where Billionaire Investors' Capital Is Flowing
Cathie Wood first invested in Kaspi back in 2020 / Photo: LinkedIn / Cathie Wood
News·
"The Queen of Traders," Cathie Wood, is investing in Kazakhstan. Which stock did she choose?
A Cathie Wood ETF has invested in Scribe, a clinical-stage developer of gene therapies for heart diseases / Photo: Facebook / ARK Invest
Small Caps·
Small caps last week: Cathie Wood’s Scribe bet, deals to acquire Forte Bio and CBIZ
A Cathie Wood ETF has invested in Scribe, a clinical-stage developer of gene therapies for heart diseases / Photo: LinkedIn / Catherinedwood
Small Caps·
Cathie Wood's ARK Genomic Revolution ETF buys newly public biotech Scribe
The massive Starship rocket was designed by SpaceX for flights to Mars / Photo: X/SpaceX
News·
SpaceX canceled the Starship launch due to engine problems. The stock price fell again.
Cathie Woods funds bought $17 million worth of SpaceX stock / Photo: X/SpaceX
News·
Cathie Wood bought SpaceX shares during a dip ahead of a new Starship rocket test
Load more